• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人卵巢癌紫杉醇耐药细胞系的蛋白质组学分析

Proteomic analysis of human ovarian cancer paclitaxel-resistant cell lines.

作者信息

Cao Lanqin, Li Xin, Zhang Yi, Peng Fang, Yi Hong, Xu Yan, Li Xinguo, Wang Qian

机构信息

Department of Gynecology and Obstetrics, Xiangya Hospital, Central South University, Changsha 410008, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Apr;35(4):286-94. doi: 10.3969/j.issn.1672-7347.2010.04.002.

DOI:10.3969/j.issn.1672-7347.2010.04.002
PMID:20448348
Abstract

OBJECTIVE

To study the proteins related to paclitaxel-resistant of ovarian cancer cell line.

METHODS

The total proteins of paclitaxel-resistant and paclitaxel-sensitive human ovarian cancer cell lines were separated by 2-dimensional gel electrophoresis (2-DE). The differentially expressed proteins were analyzed using image analysis software. The differential proteins were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Western blot was used to determine the differential expression levels of the 2 proteins.

RESULTS

Forty differentially expressed proteins were found by image analysis software, and 24 differential proteins were identified by mass spectrometry. These proteins included proliferation cell nuclear antigen (PCNA), nm23, prohibitin (PHB), annexin, alpha-enolase, heat shock protein (HSP), and so on.

CONCLUSION

Twenty-four proteins in human ovarian cancer cell lines of paclitaxel-resistant and paclitaxel-sensitive are found by proteomic techniques, which may be involved in the paclitaxel-resistance of human ovarian cancer cells.

摘要

目的

研究卵巢癌细胞系中与紫杉醇耐药相关的蛋白质。

方法

采用二维凝胶电泳(2-DE)分离紫杉醇耐药和紫杉醇敏感的人卵巢癌细胞系的总蛋白。使用图像分析软件分析差异表达蛋白。使用基质辅助激光解吸/电离飞行时间质谱鉴定差异蛋白。采用蛋白质免疫印迹法测定这两种蛋白的差异表达水平。

结果

图像分析软件发现40种差异表达蛋白,质谱鉴定出24种差异蛋白。这些蛋白包括增殖细胞核抗原(PCNA)、nm23、抑制素(PHB)、膜联蛋白、α-烯醇化酶、热休克蛋白(HSP)等。

结论

通过蛋白质组学技术发现了紫杉醇耐药和紫杉醇敏感的人卵巢癌细胞系中的24种蛋白质,它们可能与人卵巢癌细胞的紫杉醇耐药有关。

相似文献

1
Proteomic analysis of human ovarian cancer paclitaxel-resistant cell lines.人卵巢癌紫杉醇耐药细胞系的蛋白质组学分析
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Apr;35(4):286-94. doi: 10.3969/j.issn.1672-7347.2010.04.002.
2
Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.在耐紫杉醇的卵巢癌细胞系SKOV3-TR30中,纺锤体检查点减弱,BubR1表达降低。
Gynecol Oncol. 2007 Apr;105(1):66-73. doi: 10.1016/j.ygyno.2006.10.061. Epub 2007 Jan 17.
3
SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.Src 酪氨酸激酶和多药耐药蛋白 1 的抑制作用独立发挥,但协同作用以恢复耐紫杉醇卵巢癌细胞对紫杉醇的敏感性。
Cancer Res. 2005 Nov 15;65(22):10381-8. doi: 10.1158/0008-5472.CAN-05-1822.
4
Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells.紫杉醇耐药相关 hnRNP A2 和 GDI 2 蛋白在人卵巢癌细胞中的蛋白质组学鉴定。
J Proteome Res. 2010 Nov 5;9(11):5668-76. doi: 10.1021/pr100478u. Epub 2010 Oct 15.
5
Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.卵巢癌和乳腺癌细胞系中紫杉醇耐药相关基因的描述
Cancer Chemother Pharmacol. 2005 Mar;55(3):277-85. doi: 10.1007/s00280-004-0878-y. Epub 2004 Nov 24.
6
[Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].[人卵巢癌细胞系及其铂耐药克隆的蛋白质组学分析]
Zhonghua Fu Chan Ke Za Zhi. 2006 Sep;41(9):584-7.
7
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.人卵巢癌细胞及其铂类耐药亚系的线粒体比较蛋白质组学。
Proteomics. 2010 Nov;10(21):3789-99. doi: 10.1002/pmic.200900685.
8
[Differential proteomic analysis of drug resistant A549/DDP cell lines in human lung adenocarcinoma].[人肺腺癌耐药A549/DDP细胞系的差异蛋白质组学分析]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Aug;35(8):854-60. doi: 10.3969/j.issn.1672-7347.2010.08.013.
9
Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.利用cDNA微阵列技术进行的基因表达谱分析显示,RhoGDI是卵巢癌中紫杉醇耐药性的一个预测标志物。
Oncol Rep. 2006 May;15(5):1265-71.
10
Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.伏立诺他(SAHA)与紫杉醇对卵巢癌细胞系及患者原发性卵巢癌细胞治疗效果的比较评估。
BMC Cancer. 2006 Jul 11;6:183. doi: 10.1186/1471-2407-6-183.

引用本文的文献

1
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer.膜联蛋白 A1 的过表达是上皮性卵巢癌患者总生存期延长的独立预测因素。
In Vivo. 2020 Jan-Feb;34(1):177-184. doi: 10.21873/invivo.11759.
2
Platelet protein biomarker panel for ovarian cancer diagnosis.用于卵巢癌诊断的血小板蛋白质生物标志物组合
Biomark Res. 2018 Jan 12;6:2. doi: 10.1186/s40364-018-0118-y. eCollection 2018.
3
Three are better than one: plasminogen receptors as cancer theranostic targets.三比一好:纤溶酶原受体作为癌症治疗和诊断的靶点。
Exp Hematol Oncol. 2013 Apr 17;2(1):12. doi: 10.1186/2162-3619-2-12.